ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 984,93
-0,99%
Dow Jones
37 903,29
0,23%
DAX
17 932,17
-1,10%
Brent Oil
83,505
-0,04%
Bitcoin
57 597,38
-1,10%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. L'Europe
  5. EU
  6. Oxurion NV (OXUR)

  7. Oxurion NV (OXUR) Actualités

OXUR

Oxurion NV (OXUR)

Oxurion NV
De:
Trier par:
 Showing the most relevant articles for your search:EU:OXUR
DateHeureSourceTitreSymboleSociété
25/04/202419h00GlobeNewswire Inc.Oxurion Receives Transparency Notification from Atlas Special Opportunities LLCEU:OXUROxurion NV
15/04/202417h16GlobeNewswire Inc.Publication Annual Report – Annual Shareholders' MeetingEU:OXUROxurion NV
11/04/202419h00GlobeNewswire Inc.Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLCEU:OXUROxurion NV
10/04/202419h00GlobeNewswire Inc.Oxurion Receives EUR 450,000 in the framework of the Atlas Funding Program : Eleventh tranche fully issued and paid-upEU:OXUROxurion NV
05/04/202414h00GlobeNewswire Inc.Postponement Annual Shareholders Meeting - Amendment financial calendarEU:OXUROxurion NV
27/03/202419h00GlobeNewswire Inc.Information on the Total Number of Voting Rights (Denominator) following Conversion Notices from Atlas - Amended versionEU:OXUROxurion NV
26/03/202419h00GlobeNewswire Inc.Information on the Total Number of Voting Rights (Denominator) following Conversion Notices from AtlasEU:OXUROxurion NV
25/03/202419h10GlobeNewswire Inc.OXURION announces its presence at the Paris SmallCap event on March 28, 2024.EU:OXUROxurion NV
05/03/202419h00GlobeNewswire Inc.Oxurion Receives EUR 300,000 in the framework of the Atlas Funding Program Tenth tranche fully issued and paid-upEU:OXUROxurion NV
22/01/202422h02GlobeNewswire Inc.Oxurion Announces New Strategic Orientation to De-risk and DiversifyEU:OXUROxurion NV
28/12/202321h15GlobeNewswire Inc.Oxurion Avoids Bankruptcy, Announces Board and Management Changes and Enters into Binding Letter of Intent with its Main Creditor AtlasEU:OXUROxurion NV
20/11/202307h00GlobeNewswire Inc.Oxurion Discloses Topline Data from KALAHARI Phase 2, Part B Trial of Novel PKal Inhibitor THR-149 in Diabetic Macular EdemaEU:OXUROxurion NV
19/11/202321h00GlobeNewswire Inc.Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from AtlasEU:OXUROxurion NV
16/11/202319h00GlobeNewswire Inc.Oxurion Receives EUR 1.0 Million under Amended Atlas Funding Program   Total of EUR 3.5 Million in Unconditional Funding Allowing Company to Reach Topline Data from KALAHARI Trial This YearEU:OXUROxurion NV
25/10/202308h00GlobeNewswire Inc.Oxurion Receives EUR 1.5 Million under Amended Atlas Funding Program; Total of EUR 3.5 Million in Unconditional Funding Allowing Company to Achieve Topline Data from KALAHARI TrialEU:OXUROxurion NV
29/09/202319h00GlobeNewswire Inc.Oxurion Publishes First Half 2023 ResultsEU:OXUROxurion NV
18/09/202308h04GlobeNewswire Inc.Oxurion Receives First EUR 1 Million under Amended Atlas Funding ProgramEU:OXUROxurion NV
11/09/202308h00GlobeNewswire Inc.Oxurion Announces Key Amendments to Atlas and Kreos/Pontifax Agreements Enabling KALAHARI Trial to Progress to Topline Results in 2023EU:OXUROxurion NV
11/08/202308h08GlobeNewswire Inc.Oxurion Receives Funding of EUR One Million under Atlas Special Opportunities LLC (Atlas) Funding ProgramEU:OXUROxurion NV
26/07/202319h00GlobeNewswire Inc.Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLEU:OXUROxurion NV
25/07/202308h00GlobeNewswire Inc.Oxurion Receives Upfront Payment of $400,000 Following Oncurious Asset License by VIB  EU:OXUROxurion NV
14/07/202319h00GlobeNewswire Inc.Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC  EU:OXUROxurion NV
15/06/202319h02GlobeNewswire Inc.Oxurion Issues EUR 1.0 million in Bonds for Tranche 3 of the Funding Program with Atlas Special Opportunities LLCEU:OXUROxurion NV
12/06/202320h00GlobeNewswire Inc.Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC  EU:OXUROxurion NV
12/06/202308h00GlobeNewswire Inc.Oxurion Finalizes Enrollment in KALAHARI Phase 2, Part B Trial of Novel PKal Inhibitor THR-149 in Diabetic Macular EdemaEU:OXUROxurion NV
09/06/202308h00GlobeNewswire Inc.Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from ATLASEU:OXUROxurion NV
05/06/202319h00GlobeNewswire Inc.Oxurion Announces Results of the Extraordinary Shareholders’ Meeting of 22 May 2023EU:OXUROxurion NV
01/06/202308h00GlobeNewswire Inc.Oxurion to Participate in Upcoming ConferencesEU:OXUROxurion NV
25/05/202321h00GlobeNewswire Inc.Oxurion Reaches Enrollment Target in KALAHARI Phase 2, Part B Trial of Novel PKal Inhibitor THR-149 in Diabetic Macular EdemaEU:OXUROxurion NV
22/05/202319h00GlobeNewswire Inc.Oxurion Issues EUR 2.0 million in Bonds for Tranche 2 of the Funding Program with Atlas Special Opportunities LLCEU:OXUROxurion NV
 Showing the most relevant articles for your search:EU:OXUR

Dernières Valeurs Consultées

EU
CS
Axa
EU
VK
Vallourec
COIN
ETHUSD
Ethereum
EU
ACA
Credit Agricole
NASDAQ
MSFT
Microsoft
NASDAQ
AMZN
Amazon.com
EU
MC
Lvmh Moet Hennessy Louis...
EU
AI
Air Liquide
EU
BN
Danone
EU
PX1
CAC 40
EU
SGO
Cie de SaintGobain
NASDAQ
AAPL
Apple
EU
GLE
Societe Generale
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés